Thomas E Mürdter

Years Active: 2017-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Rau, Nicole Janssen, Lennart Kühl, Thomas Sell, Svetlana Kalmykova, Thomas E Mürdter, Marc-H Dahlke, Christine Sers, Markus Morkel, Matthias Schwab, Roland E Kontermann, Monilola A Olayioye
Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer. Molecular cancer therapeutics 21 (5) (2022)
Corinna J Mohr, Werner Schroth, Thomas E Mürdter, Dominic Gross, Selina Maier, Benjamin Stegen, Alice Dragoi, Friederike A Steudel, Severine Stehling, Reiner Hoppe, Stephen Madden, Peter Ruth, Stephan M Huber, Hiltrud Brauch, Robert Lukowski
Subunits of BK channels promote breast cancer development and modulate responses to endocrine treatment in preclinical models. British journal of pharmacology (2020)
Janina Johänning, Patrick Kröner, Maria Thomas, Ulrich M Zanger, Astrid Nörenberg, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch, Werner Schroth, Thomas E Mürdter
The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes. Archives of toxicology 92 (3) (2017)

Thomas E Mürdter.css-eqlu8i{font-size:small;padding-left:4px;}